| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |